Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Driving after spine surgery: biomechanics, recovery pathways, and medico-legal insights

Abstract

Returning to driving is a significant milestone for patients recovering from spine surgery, representing restored independence, mobility, and mental well-being. However, this decision involves numerous challenges, including biomechanical restrictions, the effects of pain management, cognitive recovery, patient-reported outcomes, and diverse medico-legal considerations. This review consolidates current evidence on recovery timelines, biomechanical factors, and the influence of medications on driving ability. It also examines the role of regional legal frameworks and professional guidelines in shaping decisions by both patients and surgeons. Additionally, it highlights interdisciplinary approaches to enhance post-operative care and discusses the broader relevance of these findings for other medical fields, proposing future research to advance understanding in this area.

Introduction

Driving is a vital aspect of independence and quality of life in modern society, requiring the integration of biomechanical, cognitive, and psychological functions. For patients recovering from spine surgery—a procedure often associated with temporary impairments in mobility, reaction time, and pain management—the question, “When can I drive again?” is both common and complex. Addressing this involves assessing multiple factors, including the type of surgery, anatomical and neurological recovery, medication effects, and legal considerations.

Safe driving depends on a combination of physical abilities, such as reaction time, foot transfer, and braking force, alongside cognitive skills like decision-making and alertness [1,2,3]. Spine surgery can temporarily compromise these abilities due to postoperative pain, restricted mobility, sedation from anesthesia, and the use of medications such as opioids [4, 5]. Recovery timelines also vary depending on the procedure type—cervical versus lumbar or fusion versus decompression—which directly impacts functional benchmarks [3, 6]. The absence of standardized guidelines further complicates recommendations, leaving clinicians to rely on subjective judgment rather than evidence-based protocols [4, 7, 8]. Jurisdictional differences in assessing driving readiness add another layer of variability, leaving both patients and clinicians with inconsistent guidance.

This paper presents a narrow review of the existing research on returning to driving after spine surgery, focusing on post-operative recovery timelines, biomechanical and cognitive recovery, medication effects, and psychosocial outcomes. Rather than providing a broad overview of the entire field, we selectively include the most relevant and recent studies to offer a concise yet insightful analysis. This approach ensures that our discussion remains directly applicable to clinical practice and patient care. Additionally, we explore the broader implications for interdisciplinary practices, highlighting how insights from spine surgery research could inform protocols in other medical fields.

Timelines for returning to driving after spine surgery

The appropriate timing for resuming driving after spine surgery varies based on the procedure and individual patient factors (Table 1). Recommendations are primarily derived from professional societies and surgeon surveys [1, 4, 6,7,8,9]. However, there is no clear consensus among surgeons regarding post-operative driving restrictions, with experienced surgeons often favoring earlier timelines for return to driving [10].

Table 1 Driving recovery time after spinal surgery

Cervical spine surgery

Recent studies offer valuable insights into recovery timelines following cervical spine surgeries. For anterior cervical discectomy and fusion (ACDF) and cervical disc arthroplasty (CDA), most patients resume driving and work within 16 days post-surgery [5]. Nevertheless, some evidence suggests a 6-week recovery period before safely returning to driving after anterior cervical procedures [9, 11]. Kelly et al. [12] reported that the majority of patients undergoing single-level ACDF or CDA can safely resume unrestricted driving within 6 weeks post-surgery. CDA has shown better long-term outcomes compared to ACDF, including improved driving-related disability, higher overall success rates, and reduced need for secondary surgeries [13, 14]. For patients with cervical spondylotic myelopathy (CSM), 72% reported improved driving ability within 24 months post-surgery, driven by reduced neck pain and enhanced leg function [15]. Recovery is influenced by preoperative disability, occupation type, and education level [5]. Functional metrics such as the Neck Disability Index (NDI) and modified Japanese Orthopaedic Association (mJOA) scores are strongly correlated with post-surgical driving ability [9]. These findings are critical for preoperative counseling and setting realistic recovery expectations for cervical spine surgery patients.

Lumbar spine surgery

Studies on resuming driving after lumbar spine surgery present mixed results. For patients undergoing surgery for lumbar disc herniation, driving may be resumed shortly after hospital discharge [16]. One study found no significant differences in driver reaction time (DRT) before and after lumbar surgery, suggesting that patients undergoing single-level lumbar fusion may safely drive within 2–3 weeks post-surgery if they are not taking opioids [6]. However, a more cautious approach recommends avoiding driving for up to three months after lumbar spinal fusion, as increased reaction times have been observed at discharge [17]. For minimally invasive transforaminal lumbar interbody fusion (MI-TLIF), a median return-to-driving time of 18.5 days was reported, with 96.4% of patients resuming driving [18]. Overall, evidence regarding safe driving timelines after spinal surgery remains limited and inconsistent, underscoring the need for further research to establish clear, evidence-based guidelines.

Biomechanical recovery and driving readiness

Importance of driving biomechanics

Driving requires the coordination of several biomechanical functions, including reaction time, trunk stability, neck mobility, and limb coordination. Spine surgery, particularly cervical fusion and lumbar decompression, can significantly impact these components. Studies indicate that impairments in brake response time (BRT) and foot transfer speed can persist for weeks or months following surgery, which may compromise driving safety [3, 19].

Evidence from driving simulators

Successful driving depends on the recovery of critical biomechanical factors, such as reaction time, neck mobility, trunk stability, and pain-free strength. Research on DRT and BRT has been crucial for assessing post-surgical driving readiness. Driving simulators are often used to collect these metrics [2, 3, 6]. Liebensteiner et al. [2] observed prolonged BRTs in lumbar fusion patients, with significant deficits lasting up to 3 months after surgery. Similarly, Hofmann et al. [3] found weaker braking force in lumbar fusion patients compared to their preoperative levels. Thaler et al. [16] reported that driving reaction times improved after surgery for lumbar disc herniation in patients with left-side and right-side radiculopathy, though they remained slower than those of healthy controls. DRT, a key indicator of safe driving, is influenced by factors such as pain, opioid use, and cognitive function [1]. The type of spinal intervention, the number of levels involved, and the anatomical location of the surgery all impact the recovery of DRT [1, 6]. These findings highlight that driving readiness is not just about general physical recovery, like walking ability, but also about specific functions essential for vehicle operation, such as braking force and the range of motion in the neck for head checks.

Despite growing evidence from simulator-based studies, the real-world applicability of these findings remains limited. Few studies have incorporated on-road driving assessments [9], which could help validate simulator results. Additionally, research has not sufficiently integrated other factors like trunk strength and cognitive distraction into functional driving assessments. Longer follow-up studies are also needed to determine whether driving capabilities decline over time due to sustained biomechanical limitations or chronic post-operative pain.

The cognitive and pharmacological impact on driving safety

Role of opioids

Pain can significantly impair driving readiness by affecting reaction time and physical capability [20, 21]. Effective pain management strategies, such as physical therapy, are crucial for improving recovery and facilitating a return to safe driving [3]. While opioids remain essential for post-surgical pain relief, they pose concerns about driving safety due to their effects on reaction time, coordination, and alertness [22]. The impact of opioids on driving ability is mixed. Some studies suggest that patients on stable opioid regimens for chronic pain perform similarly to healthy controls [23], while driving impairment is more likely when opioids are used during therapy initiation, illicitly, or combined with other psychoactive substances [24]. Given the variability in opioid response and other factors like pain intensity, driving safety assessments should be individualized [25]. Though opioids are vital for recovery, a balance must be struck between effective pain management and minimizing patient and societal risks [26].

Preoperative opioid use is associated with adverse outcomes in patients undergoing spine surgery. Studies have shown that increased preoperative opioid consumption predicts worse patient-reported outcomes, including decreased quality of life and increased disability scores [27]. Greater preoperative opioid use is also linked to increased postoperative opioid demand and decreased likelihood of opioid independence at 12 months post-surgery [28]. The duration of preoperative opioid use is a significant predictor of continued use following surgery, with longer use associated with higher risk [29]. In workers’ compensation settings, preoperative opioid use is associated with reduced odds of returning to work after spine surgery. Patients using opioids preoperatively have approximately half the odds of achieving stable return to work or returning to work within one year post-surgery compared to non-users [30]. However, Subramanian T et al. [5] found that preop narcotics had no impact on return to drive by 15 d after cervical spine surgery. While preoperative opioid use is generally associated with poorer postoperative outcomes and reduced likelihood of returning to work, its specific impact on return to driving remains unclear. Future research should focus on larger cohort studies and objective assessments of driving performance to better understand the relationship between preoperative opioid use and postoperative driving readiness.

Muscle relaxants, neuromodulators, and epidural steroid injections

Centrally acting muscle relaxants, commonly prescribed for musculoskeletal issues, have been linked to impaired driving performance and increased traffic risks [31]. These medications can cause sedation and other side effects, raising concerns about their abuse potential [32]. Research has shown an increase in muscle relaxants in blood tests of suspected drug-impaired drivers, particularly carisoprodol and its metabolite meprobamate [33]. While these drugs may offer short-term relief for acute low back pain, their effectiveness is limited, and they are not superior to alternatives like acetaminophen or NSAIDs [34]. Clinicians should consider safer pain management options, educate patients about the risks of impaired driving, and choose medications based on side effects and potential interactions [31, 34].

Gabapentin, a neuromodulator, has shown efficacy in managing postoperative pain following spine surgery. Research on neuromodulators like gabapentin and pregabalin suggests potential impacts on driving ability. Gabapentin use in driving under the influence cases has increased, with a 7.9% positivity rate observed from 2020 to 2022 [35]. Side effects such as drowsiness and loss of coordination can affect driving performance [35, 36]. Comparative studies found that gastroretentive gabapentin showed less driving impairment than standard gabapentin [37]. Pregabalin, another gabapentinoid, did not significantly impair driving performance in simulator tests but mildly reduced training effects [38]. These findings emphasize the need for careful consideration when prescribing gabapentinoids to patients who drive and highlight the importance of further research to better understand their effects on driving ability after spine surgery.

Epidural steroid injections (ESI) are widely used for managing spinal pain. A study by Zachary L. McCormick et al. [39] evaluated the effects of ESI without sedation on driving ability, finding no significant impact on reaction time or neurocognitive function. However, individual responses may vary depending on factors such as pain relief, neurological sensitivity, and overall health. The authors suggest that driving recommendations should be tailored to each patient rather than applying uniform restrictions, allowing for a safe return to driving based on individual recovery. Similarly, research by Marion Hanley et al. [40] found no significant changes in brake response time following CT-guided cervical spine nerve root injections, indicating that most patients can resume driving shortly after the procedure. Nonetheless, individual differences should be accounted for when providing guidance on driving readiness. Future studies should focus on larger patient cohorts and incorporate objective driving simulations to further assess the impact of these procedures on real-world driving performance.

Medication tapering and readiness

Guidelines now recommend tapering opioids for patients with chronic non-cancer pain, though there is no consensus on managing withdrawal symptoms or monitoring outcomes during this process [41]. A patient-centered, integrative approach involving collaboration between physicians, physical therapists, and patients has shown promise in addressing both pain management and opioid tapering [42]. This approach shifts the focus from complete pain relief to minimizing its impact on quality of life [43]. A biopsychosocial model of care is vital to ensure patient safety during tapering, with physical therapists playing a crucial role in understanding pain mechanisms and coordinating care across disciplines [44].

Psychological aspects

Cognitive behavioral therapy (CBT) has proven effective in addressing psychological barriers related to driving and recovery post-surgery. A pilot study showed that CBT significantly reduced driving-related fear, improving cognitive factors associated with driving [45]. For spine surgery patients, CBT has also been beneficial in reducing fear-avoidance behaviors and enhancing psychological well-being [46]. A case series focused on cognitive-behavioral-based physical therapy (CBPT) for patients with high fear of movement after lumbar surgery found significant reductions in pain and disability [47]. Furthermore, a meta-analysis of CBT for spinal cord injury patients revealed substantial improvements in assertiveness, coping, self-efficacy, depression, and quality of life [48]. These findings suggest that CBT and similar interventions are valuable tools for addressing the psychological aspects of recovery and rehabilitation after spine surgery or injury.

Future research should focus on exploring the relationship between opioid tapering schedules and driving performance. Additionally, studies should examine the feasibility of integrating non-opioid pain management strategies with CBT to mitigate driving-related impairments in spine surgery patients.

Patient-reported outcomes and psychosocial considerations

Quality-of-life measures linked to driving readiness

Measures such as the NDI driving subscale and the EQ-5D have consistently demonstrated the link between driving readiness and key recovery factors like independence, mobility, and overall life satisfaction [15, 49, 50]. The ability to drive significantly improves post-recovery quality of life by enabling patients to resume daily activities and reduce reliance on caregivers. While some studies associate driving with the ability to return to work and decreased dependence on others, there is still a lack of comprehensive quantitative data on the broader economic impacts, such as workforce reintegration and long-term financial stability [15, 18]. Filling this research gap could provide deeper insights into the economic advantages of regaining the ability to drive.

Psychosocial impacts and gaps

Post-surgical driving restrictions often result in a loss of autonomy, increased dependence, and heightened psychosocial stress. These limitations are particularly challenging for individuals with jobs requiring regular commuting, as they can lead to financial strain and reduced productivity. The issue is even more pronounced in areas with limited alternative transportation options.

However, there is a significant gap in studies that comprehensively measure the long-term psychosocial and economic effects of driving restrictions. Expanding research in this area is crucial to better understand the relationship between driving readiness, workforce participation, and overall well-being.

Medico-legal considerations

Legal requirements for reporting unfit drivers vary across jurisdictions, with most Canadian provinces mandating physician reporting [51]. In Canada, physicians have a legal responsibility to identify and counsel patients about medical conditions that may impair driving ability [52]. Australian cases have raised concerns about doctors’ legal liability for decisions regarding patient fitness to drive [53]. In multiple countries, transport regulatory bodies often fail to provide explicit guidelines for returning to driving after surgical procedures, including spine surgery, hip arthroplasty, or knee arthroplasty. This lack of clear guidance places the burden of decision-making on treating physicians, who must assess recovery timelines and individual patient capabilities [54]. Physicians are frequently relied upon not only by patients but also by insurance companies, who defer to medical opinions when determining fitness to drive post-surgery [54]. This reliance can expose physicians to significant legal risks. For example, physicians may face lawsuits from patients for failing to provide adequate counseling on the risks of returning to driving prematurely. Additionally, they may be held liable by accident victims if it can be demonstrated that they should have reasonably foreseen the danger posed by allowing an unfit patient to resume driving [52].

To mitigate these risks, thorough documentation of discussions about driving restrictions and recovery milestones is strongly recommended. This includes providing patients with clear, evidence-based guidance tailored to their condition, documenting their understanding of the advice, and outlining any uncertainties about recovery timelines [54]. Collaboration with multidisciplinary teams, including occupational therapists and physical therapists, may further assist in providing a comprehensive assessment of driving readiness. Nonetheless, the medico-legal challenges highlight the need for standardized guidelines to support physicians in making informed decisions while minimizing legal exposure.

Conclusion and future directions

This review underscores the multifaceted nature of assessing driving readiness after spine surgery, shaped by biomechanical factors, medication effects, clinical guidelines, and regional legal frameworks. Clinicians should provide individualized recommendations based on surgical type, functional recovery, and medication use. Conducting reaction time tests or on-road driving assessments may help determine readiness.

Future research should focus on integrating simulator-based and real-world driving evaluations to establish clear, evidence-based timelines for safe driving resumption. Additionally, efforts are needed to develop standardized recommendations that can be applied consistently across different jurisdictions and surgical procedures. Furthermore, the insights gained from this research should be extended to inform return-to-driving policies for individuals recovering from other types of surgeries or managing chronic health conditions. By uniting biomechanics, patient recovery outcomes, and legal considerations, the goal is to create standardized and globally applicable strategies to optimize post-surgical recovery and reintegration.

Data availability

No datasets were generated or analysed during the current study.

References

  1. Alhammoud A, Alkhalili K, Hannallah J, Ibeche B, Bajammal S, Baco AM. Driving safety after spinal surgery: A systematic review. Asian Spine J. 2017;11:319–27.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Liebensteiner MC, Birkfellner F, Thaler M, Haid C, Bach C, Krismer M. Driving reaction time before and after primary fusion of the lumbar spine. Spine (Phila Pa 1976). 2010;35:330–5.

  3. Hofmann UK, Wittmann S, Fischer AN, Jordan M, Feierabend MM, Rondak IC, et al. Influence of spine surgery on the ability to perform an emergency stop while driving a car. J Back Musculoskelet Rehabil. 2018;31:29–36.

    Article  PubMed  Google Scholar 

  4. Moses MJ, Tishelman JC, Hasan S, Zhou PL, Zevgaras I, Smith JS, et al. Lack of consensus in physician recommendations regarding return to driving after cervical spine surgery. Spine (Phila Pa 1976).2018;43:1411–7.

  5. Subramanian T, Shinn DJ, Korsun MK, Shahi P, Asada T, Amen TB, et al. Recovery Kinetics after Cervical Spine Surgery. Spine (Phila Pa 1976). 2023;48:1709–16

  6. Scott TP, Pannel W, Savin D, Ngo SS, Ellerman J, Toy K, et al. When is it safe to return to driving after spinal surgery?? Global Spine J. 2015;5:274–81.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Hiett J, Chan D, Clarke A, Challinor H. Hourigan PJIJoT, rehabilitation. Returning to work and driving after spinal surgery: A web-based survey investigating the opinions of UK spinal surgeons. Int J Ther Rehabil. 2015;22:181–6.

  8. Rodriguez EK, et al. Commentary on an article by MAJ Justin Orr, MD, et al.: The effect of immobilization devices and left-foot adapter on brake-response time.J Bone Joint Surg Am. 2010;92:e38.

  9. Ding BTK, Chan ML, Yu CS, Oh JY-L. Return to driving is safe 6 weeks after anterior cervical surgery for symptomatic cervical degenerative disc disease. Clin Spine Surg. 2023;36:E218–25.

  10. Moses MJ, Tishelman JC, Hasan S, Zhou PL, Zevgaras I, Smith JS, et al. Lack of consensus in physician recommendations regarding return to driving after cervical spine surgery. Spine (Phila Pa 1976). 2018;43:1411–7.

    Article  PubMed  Google Scholar 

  11. DiSilvestro KJ, Santoro AJ, Tjoumakaris FP, Levicoff EA, Freedman KB. When can I drive after orthopaedic surgery?? A systematic review. Clin Orthop Relat Res. 2016;474:2557–70.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Kelly MP, Mitchell MD, Hacker RJ, Riew KD, Sasso RC. Single-level degenerative cervical disc disease and driving disability: results from a prospective, randomized trial. Global Spine J. 2013;3:237–42.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Jain D, Kelly MP, Gornet MF, Kenneth Burkus J, Hodges SD, Dryer RF, et al. Impact of cervical disc arthroplasty vs anterior cervical discectomy and fusion on driving disability: post hoc analysis of a randomized controlled trial with 10-Year Follow-Up. Int J Spine Surg. 2022;16:95–101.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Goldstein ZH, Boody B, Sasso R. Two-Level anterior cervical discectomy and fusion versus cervical disc Arthroplasty-Long-Term evidence update. Int J Spine Surg. 2020;14:S36–40.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Agarwal N, Johnson SE, Bydon M, Bisson EF, Chan AK, Shabani S, et al. Cervical spondylotic myelopathy and driving abilities: defining the prevalence and long-term postoperative outcomes using the quality outcomes database. J Neurosurg Spine. 2024;40:630–41.

    Article  PubMed  Google Scholar 

  16. Thaler M, Lechner R, Foedinger B, Haid C, Kavakebi P, Galiano K, et al. Driving reaction time before and after surgery for lumbar disc herniation in patients with radiculopathy. Eur Spine J. 2012;21:2259–64.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Liebensteiner MC, Birkfellner F, Deibl M, Haid C, Krismer M, Dammerer D. Driving abstinence is necessary after lumbar spinal fusion: a prospective cohort study. Int Orthop. 2016;40:1261–5.

    Article  PubMed  Google Scholar 

  18. Shinn D, Mok JK, Vaishnav AS, Louie PK, Sivaganesan A, Shahi P, et al. Recovery kinetics after commonly performed minimally invasive spine surgery procedures. Spine (Phila Pa 1976). 2022;47:1489–96.

    Article  PubMed  Google Scholar 

  19. Schwienbacher S, Aghayev E, Hofmann UK, Jordan M, Marmotti A, Röder C, et al. Driving and emergency braking May be impaired after tibiotalar joint arthrodesis: conclusions after a case series. Int Orthop. 2015;39:1335–41.

    Article  PubMed  Google Scholar 

  20. Al-khayer A, Schueler A, Kruszewski G, Armstrong G, Grevitt MP. Driver reaction time before and after treatment for lumbar radiculopathy. Spine (Phila Pa 1976). 2008;33:1696–700.

    Article  PubMed  Google Scholar 

  21. Chen V, Chacko AT, Costello FV, Desrosiers N, Appleton P, Rodriguez EK. Driving after musculoskeletal injury. Addressing patient and surgeon concerns in an urban orthopaedic practice. J Bone Joint Surg Am. 2008;90:2791–7.

    Article  PubMed  Google Scholar 

  22. Vainio A, Ollila J, Matikainen E, Rosenberg P, Kalso E. Driving ability in cancer patients receiving long-term morphine analgesia. Lancet (London England). 1995;346:667–70.

    Article  CAS  PubMed  Google Scholar 

  23. Byas-Smith MG, Chapman SL, Reed B, Cotsonis G. The effect of opioids on driving and psychomotor performance in patients with chronic pain. Clin J Pain. 2005;21:345–52.

    Article  PubMed  Google Scholar 

  24. Cameron-Burr KT, Conicella A, Neavyn MJ. Opioid use and driving performance. J Med Toxicology: Official J Am Coll Med Toxicol. 2021;17:289–308.

    Article  CAS  Google Scholar 

  25. Sabatowski R, Kaiser U, Gossrau G. [Opioids in the management of chronic pain and driving ability]. Volume 45. Intensivmedizin, Notfallmedizin, Schmerztherapie: AINS.: Anasthesiologie; 2010. pp. 384–5.

    Google Scholar 

  26. Macintyre PE, Quinlan J, Levy N, Lobo DN. Current issues in the use of opioids for the management of postoperative pain: A review. JAMA Surg. 2022;157:158–66.

    Article  PubMed  Google Scholar 

  27. Lee D, Armaghani S, Archer KR, Bible J, Shau D, Kay H, et al. Preoperative opioid use as a predictor of adverse postoperative Self-Reported outcomes in patients undergoing spine surgery. J Bone Joint Surg Am. 2014;96:e89.

    Article  PubMed  Google Scholar 

  28. Armaghani SJ, Lee DS, Bible JE, Archer KR, Shau DN, Kay H, et al. Preoperative opioid use and its association with perioperative opioid demand and postoperative opioid independence in patients undergoing spine surgery. Spine (Phila Pa 1976). 2014;39:E1524–30.

    Article  PubMed  Google Scholar 

  29. Schoenfeld AJ, Belmont PJ Jr., Blucher JA, Jiang W, Chaudhary MA, Koehlmoos T, et al. Sustained preoperative opioid use is a predictor of continued use following spine surgery. J Bone Joint Surg Am. 2018;100:914–21.

    Article  PubMed  Google Scholar 

  30. Tefera YG, Gray S, Nielsen S, Collie A. Preoperative opioid use and postoperative return to work following spinal surgery in workers’ compensation settings: a systematic review and meta-analysis. Int J Surg (London England). 2024;110:1781–92.

    Article  Google Scholar 

  31. Hetland A, Carr DB. Medications and impaired driving. Annals Pharmacotherapy. 2014;48:494–506.

    Article  Google Scholar 

  32. Waldman HJ. Centrally acting skeletal muscle relaxants and associated drugs. J Pain Symptom Manag. 1994;9:434–41.

    Article  CAS  Google Scholar 

  33. Bramness JG, Skurtveit S, Grung M, Mørland J. [Centrally acting muscle relaxants and traffic hazards]. Tidsskrift Den Norske Laegeforening: Tidsskrift Praktisk Medicin Ny Raekke. 2000;120:1966–9.

  34. See S, Ginzburg R. Choosing a skeletal muscle relaxant. Am Family Phys. 2008;78:365–70.

    Google Scholar 

  35. Bierly JJ, Chan-Hosokawa A. Gabapentin in drugged driving investigations. J Forensic Sci. 2024;69:986–92.

    Article  CAS  PubMed  Google Scholar 

  36. Peterson BL. Prevalence of Gabapentin in impaired driving cases in Washington state in 2003–2007. J Anal Toxicol. 2009;33:545–9.

    Article  CAS  PubMed  Google Scholar 

  37. Schmidt P, Rao S. Effects of Gabapentin, Pregabalin and gastroretentive Gabapentin on simulated driving, daytime sedation and cognition. Pain Manage. 2018;8:297–306.

    Article  Google Scholar 

  38. Tujii T, Kyaw WT, Iwaki H, Nishikawa N, Nagai M, Kubo M, et al. Evaluation of the effect of Pregabalin on simulated driving ability using a driving simulator in healthy male volunteers. Int J Gen Med. 2014;7:103–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  39. McCormick ZL, Schneider B, Smith C. Driving after an epidural steroid injection without sedation. Pain Med (Malden Mass). 2019;20:195–6.

    Article  Google Scholar 

  40. Hanley M, Eustace SK, Ryan DT, McLoughlin S, Hynes JP, Kavanagh EC, et al. Are brake response times altered post CT-guided cervical spine nerve root injections? Br J Radiol. 2024;97:834–7.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Hamilton M, Kwok WS, Hsu A, Mathieson S, Gnjidic D, Deyo R, et al. Opioid deprescribing in patients with chronic noncancer pain: a systematic review of international guidelines. Pain. 2023;164:485–93.

    Article  PubMed  Google Scholar 

  42. Pullen S, Marconi VC, Del Rio C, Head C, Nimmo M, O’Neil J, et al. From silos to solidarity: case study of a Patient-Centered, integrative approach to opioid tapering and chronic pain mitigation in a multidisciplinary AIDS clinic. J AIDS HIV Treat. 2021;3:4–11.

    CAS  PubMed  PubMed Central  Google Scholar 

  43. Wenger S, Drott J, Fillipo R, Findlay A, Genung A, Heiden J, et al. Reducing opioid use for patients with chronic pain: an Evidence-Based perspective. Phys Ther. 2018;98:424–33.

    Article  PubMed  Google Scholar 

  44. Covington EC, Argoff CE, Ballantyne JC, Cowan P, Gazelka HM, Hooten WM, et al. Ensuring patient protections when tapering opioids: consensus panel recommendations. Mayo Clin Proc. 2020;95:2155–71.

  45. Fischer C, Heider J, Taylor JE, Schröder A. Cognitive behavior therapy for driving fear: A pilot randomized controlled trial. Transp Res Part F: Traffic Psychol Behav. 2021;83:118–29.

    Article  Google Scholar 

  46. Passias PG, Naessig S, Ahmad W, Pierce KE, O’Connell BK, Maglaras C, et al. P67. Effects cognitive behavioral therapy on cervical spine surgery: results of a randomized controlled trial. Spine J. 2020;20:S178.

  47. Archer KR, Motzny N, Abraham CM, Yaffe D, Seebach CL, Devin CJ, et al. Cognitive-behavioral–based physical therapy to improve surgical spine outcomes: a case series. Phys Ther. 2013;93:1

  48. Dorstyn D, Mathias J, Denson LJJHP. Efficacy of cognitive behavior therapy for the management of psychological outcomes following spinal cord injury a meta-analysis. J Health Psychol. 2011;16:374–91.

  49. Croci DM, Sherrod B, Alvi MA, Mummaneni PV, Chan AK, Bydon M, et al. Differences in postoperative quality of life in young, early elderly, and late elderly patients undergoing surgical treatment for degenerative cervical myelopathy. J Neurosurg Spine. 2022;37:339–49.

    Article  PubMed  Google Scholar 

  50. Hajek A, Brettschneider C, Lühmann D, van den Bussche H, Wiese B, Mamone S, et al. Driving status and health-related quality of life among the oldest old: a population-based examination using data from the AgeCoDe-AgeQualiDe prospective cohort study. Aging Clin Exp Res. 2021;33:3109–15.

    Article  PubMed  Google Scholar 

  51. Kryworuk PW, Nickle SE. Mandatory physician reporting of drivers with medical conditions: legal considerations. Can J Cardiol. 2004;20:1324–8.

    PubMed  Google Scholar 

  52. Coopersmith HG, Korner-Bitensky NA, Mayo NE. Determining medical fitness to drive: physicians’ responsibilities in Canada. Volume 140. CMAJ: Canadian Medical Association journal = journal de l’Association medicale canadienne; 1989. pp. 375–8.

    Google Scholar 

  53. Ranson D. Medico-legal issues and driver licensing. J Law Med. 2007;15:198–200.

    PubMed  Google Scholar 

  54. Hibberd CS, Broderick JM, Nieboer M, Khoshbin A, Atrey A. Licensed and liable: Insurance, road regulations, and driving after hip and knee arthroplasty surgery. J Arthroplast. 2023;38:644–8.

    Article  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

Not applicable.

Author information

Authors and Affiliations

Authors

Contributions

ZW conceived and designed the project. CW performed the 1iterature retrieval and drafted the article. YZ and ZW critically revised the manuscript. All the authors approved the final manuscript.

Corresponding author

Correspondence to Zhongjie Wu.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, C., Zhi, Y. & Wu, Z. Driving after spine surgery: biomechanics, recovery pathways, and medico-legal insights. J Orthop Surg Res 20, 374 (2025). https://doi.org/10.1186/s13018-025-05787-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13018-025-05787-z

Keywords